Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose abobotulinum toxin A injection in allergic rhinitis
TCTR20200526014Phase 2Recruiting
- Sponsor
- Khon Kaen University
- Start
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of abobotulinumtoxinA in allergic rhinitis (AR), sponsored by Khon Kaen University. Started Jan 2018; status: recruiting.
02
Drugs
abobotulinumtoxinA
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20200526014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200526014.